Polymorphisms in inflammation pathway genes and endometrial cancer risk.

Polymorphisms in inflammation pathway genes and endometrial cancer risk.

BACKGROUND: Experimental and epidemiologic evidence have suggested that chronic inflammation may play a critical role in endometrial carcinogenesis. METHODS: To investigate this hypothesis, a two-stage study was carried out to evaluate single-nucleotide polymorphisms (SNP) in inflammatory pathway ge...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Delahanty, R, Xiang, Y, Spurdle, A, Beeghly-Fadiel, A, Long, J, Thompson, D, Tomlinson, I, Yu, H, Lambrechts, D, Dörk, T, Goodman, M, Zheng, Y, Salvesen, H, Bao, P, Amant, F, Beckmann, M, Coenegrachts, L, Coosemans, A, Dubrowinskaja, N, Dunning, A, Runnebaum, I, Easton, D, Ekici, AB, Fasching, P, Halle, M
Format:	Journal article
Język:	English
Wydane:	2013

Podobne zapisy

Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.
od: Long, J, i wsp.
Wydane: (2012)

Genome-wide association study identifies a common variant associated with risk of endometrial cancer
od: Spurdle, AB, i wsp.
Wydane: (2011)

Genome-wide association study identifies a common variant associated with risk of endometrial cancer.
od: Spurdle, AB, i wsp.
Wydane: (2011)

Germline copy number variants and endometrial cancer risk
od: Stylianou, CE, i wsp.
Wydane: (2024)

Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study.
od: Healey, C, i wsp.
Wydane: (2011)

Five endometrial cancer risk loci identified through genome-wide association analysis.
od: Cheng, T, i wsp.
Wydane: (2016)

Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer.
od: Painter, J, i wsp.
Wydane: (2016)

Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses
od: Painter, JN, i wsp.
Wydane: (2018)

Identification of nine new susceptibility loci for endometrial cancer
od: O'Mara, TA, i wsp.
Wydane: (2018)

A common variant at the 14q32 endometrial cancer risk locus activates AKT1 through YY1 binding
od: Painter, J, i wsp.
Wydane: (2016)

A common variant at the 14q32 endometrial cancer risk locus activates AKT1 through YY1 binding
od: Painter, J, i wsp.
Wydane: (2016)

Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology.
od: Canfell, K, i wsp.
Wydane: (2008)

Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
od: Cheng, T, i wsp.
Wydane: (2015)

INCIDENCE OF ENDOMETRIAL CARCINOMA
od: Doll, R, i wsp.
Wydane: (1976)

A cost-utility analysis of microwave endometrial ablation versus thermal balloon endometrial ablation.
od: Kilonzo, M, i wsp.
Wydane: (2010)

The influence of menstrual cycle and endometriosis on endometrial methylome.
od: Saare, M, i wsp.
Wydane: (2016)

Frequent homologous recombination deficiency in high-grade endometrial carcinomas
od: Jonge, D, i wsp.
Wydane: (2018)

Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study
od: Epstein, E, i wsp.
Wydane: (2017)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
od: Koukourakis, M, i wsp.
Wydane: (2005)

Hormone replacement therapy and endometrial carcinoma.
od: Doll, R, i wsp.
Wydane: (1977)

Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells
od: Subramaniam, K.S., i wsp.
Wydane: (2013)

Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neo-antigen burden and immune response
od: Temko, D, i wsp.
Wydane: (2018)

Clinical outcomes from a randomised comparison of Microwave Endometrial Ablation with Thermal Balloon endometrial ablation for the treatment of heavy menstrual bleeding.
od: Sambrook, A, i wsp.
Wydane: (2009)

Genetic susceptibility to endometrial cancer
od: Cheng, T
Wydane: (2015)

Adjuvant radiotherapy for stage I endometrial cancer.
od: Kong, A, i wsp.
Wydane: (2012)

Adjuvant radiotherapy for stage I endometrial cancer.
od: Kong, A, i wsp.
Wydane: (2012)

Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors
od: Koutoukidis, D, i wsp.
Wydane: (2015)

An epidemiological model for prediction of endometrial cancer risk in Europe.
od: Hüsing, A, i wsp.
Wydane: (2015)

14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
od: Lee, Cheng-Han, i wsp.
Wydane: (2012)

Interpretation of somatic POLE mutations in endometrial carcinoma
od: León-Castillo, A, i wsp.
Wydane: (2020)

Integrated genomic characterization of endometrial carcinoma
od: Park, Peter J., i wsp.
Wydane: (2014)

Endometrial tissue resident memory T cells
od: Southcombe, J, i wsp.
Wydane: (2016)

Characterisation of chromatin modifiers in endometrial cancer
od: Kedzierska, KZ
Wydane: (2024)

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.
od: Key, T, i wsp.
Wydane: (1988)

Practical guidance for mismatch repair-deficiency testing in endometrial cancer
od: Stelloo, E, i wsp.
Wydane: (2016)

Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
od: Sivridis, E, i wsp.
Wydane: (2002)

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
od: Salvesen, H. B., i wsp.
Wydane: (2009)

Readmission to hospital 5 years after hysterectomy or endometrial resection in a national cohort study.
od: Clarke, A, i wsp.
Wydane: (2005)

POLE proofreading mutation, immune response and prognosis in endometrial cancer
od: Van Gool, I, i wsp.
Wydane: (2015)

Endometrial cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V, i wsp.
Wydane: (2005)